Viktor Procházka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Viktor Procházka has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Adéla Bubeníková
Department of Neurosurgery, Second Medical Faculty, Charles University and Motol University Hospital, Prague, Czech Republic
2 shared publications - Ondřej Bradáč
Department of Neurosurgery, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech republic
2 shared publications - Petr Skalický
Department of Neurosurgery, Second Medical Faculty, Charles University and Motol University Hospital, Prague, Czech Republic
2 shared publications - Róbert Leško
Department of Neurosurgery, Second Medical Faculty, Charles University and Motol University Hospital, Prague, Czech Republic
2 shared publications Vojtěch Novák
Department of Neurosurgery, Second Medical Faculty, Charles University and Motol University Hospital, Prague, Czech Republic
2 shared publications- Aleš Vlasák
Department of Neurosurgery, 2nd Faculty of Medicine, Charles University and University Hospital Motol and Homolka, Prague, Czech Republic
1 shared publication
Latest Publications
- Open Access
- 1 December 2025
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 167 (1) , 304
Therapeutic role of venous sinus stenting in pediatric IIH: evidence review for clinical practice
Background Idiopathic intracranial hypertension (IIH) in children is a rare but vision-threatening condition characterized by elevated intracranial pressure (ICP) without an identifiable cause. While medical therapy remains the first-line approach, a subset of pediatric patients remains refractory, necessitating surgical or endovascular interventions. Venous sinus stenting (VSS) has emerged as a promising, minimally invasive alternative to cerebrospinal fluid (CSF) shunting, but its safety and efficacy in pediatric populations are not well-defined. Methods A systematic literature review was conducted following PRISMA guidelines, focusing on pediatric patients (< 18 years) with medically refractory IIH treated with VSS. Databases searched included PubMed, ScienceDirect, Cochrane Library, and others, including studies published from January 1990 to September 2025. Data on patient selection, procedural outcomes, complications, and antiplatelet protocols were extracted and analyzed. Only studies rated ≥ 6 stars on the Newcastle–Ottawa Scale were included. Results Six primary studies were identified, reporting outcomes in 36 pediatric patients (mean age 13.32 ± 1.25 years). VSS led to marked improvement in headache (87.5%), papilledema (89.5%), and tinnitus (100%), with reduced need for acetazolamide in 66.7%. Complications included one retroperitoneal hematoma, decreased flow in the vein of Labbe and minor hemorrhagic events related to antiplatelet therapy, including epistaxis, menorrhagia, and oral bleeding leading to early discontinuation of clopidogrel. Persistent or recurrent symptoms after stenting underscore the need for individualized, multimodal evaluation, as standardized selection criteria for pediatric IIH are still lacking. The estimated retreatment rate across studies was approximately 20%, with re-stenting or CSF shunting required in select cases. Conclusion VSS appears to be a safe and effective treatment for selected pediatric IIH patients with venous sinus stenosis and demonstrable trans-stenotic gradients. However, its success relies heavily on appropriate patient selection and tailored antiplatelet management. Prospective pediatric studies and standardized guidelines are needed to clarify its optimal role in the therapeutic algorithm. Accordingly, our synthesis is intended to inform individualized decision-making in selected cases and does not constitute guideline-level recommendations.
- 1 December 2025
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 167 (1) , 304
Open AccessTherapeutic role of venous sinus stenting in pediatric IIH: evidence review for clinical practice
Background Idiopathic intracranial hypertension (IIH) in children is a rare but vision-threatening condition characterized by elevated intracranial pressure (ICP) without an identifiable cause. While medical therapy remains the first-line approach, a subset of pediatric patients remains refractory, necessitating surgical or endovascular interventions. Venous sinus stenting (VSS) has emerged as a promising, minimally invasive alternative to cerebrospinal fluid (CSF) shunting, but its safety and efficacy in pediatric populations are not well-defined. Methods A systematic literature review was conducted following PRISMA guidelines, focusing on pediatric patients (< 18 years) with medically refractory IIH treated with VSS. Databases searched included PubMed, ScienceDirect, Cochrane Library, and others, including studies published from January 1990 to September 2025. Data on patient selection, procedural outcomes, complications, and antiplatelet protocols were extracted and analyzed. Only studies rated ≥ 6 stars on the Newcastle–Ottawa Scale were included. Results Six primary studies were identified, reporting outcomes in 36 pediatric patients (mean age 13.32 ± 1.25 years). VSS led to marked improvement in headache (87.5%), papilledema (89.5%), and tinnitus (100%), with reduced need for acetazolamide in 66.7%. Complications included one retroperitoneal hematoma, decreased flow in the vein of Labbe and minor hemorrhagic events related to antiplatelet therapy, including epistaxis, menorrhagia, and oral bleeding leading to early discontinuation of clopidogrel. Persistent or recurrent symptoms after stenting underscore the need for individualized, multimodal evaluation, as standardized selection criteria for pediatric IIH are still lacking. The estimated retreatment rate across studies was approximately 20%, with re-stenting or CSF shunting required in select cases. Conclusion VSS appears to be a safe and effective treatment for selected pediatric IIH patients with venous sinus stenosis and demonstrable trans-stenotic gradients. However, its success relies heavily on appropriate patient selection and tailored antiplatelet management. Prospective pediatric studies and standardized guidelines are needed to clarify its optimal role in the therapeutic algorithm. Accordingly, our synthesis is intended to inform individualized decision-making in selected cases and does not constitute guideline-level recommendations.
- 14 August 2025
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 126 (1) , 23-34
Rethinking lumbar puncture safety: pathophysiology, diagnostic uncertainty, and research gaps in herniation risk
Lumbar puncture (LP) is a key diagnostic and therapeutic tool, yet concerns persist about its potential to induce brain herniation, especially in patients with elevated intracranial pressure (ICP). Despite ongoing debate, precise risk factors and pathophysiological mechanisms remain unclear. This systematic review aims to examine the risk of cerebellar and paradoxical brain herniation following LP, evaluate the current evidence regarding its incidence, and discuss the implications for clinical practice as well as show the gaps in research. Following PRISMA guidelines, a systematic literature review was conducted using the PubMed (MEDLINE) database. Studies from 1990 to 2024 focusing on bacterial meningitis, idiopathic intracranial hypertension, post-surgical states, and other conditions associated with elevated ICP were included. LP-related herniation was reported in diverse clinical settings, with cerebellar herniation primarily seen in bacterial meningitis and idiopathic intracranial hypertension. Herniation onset varied from minutes to days post-LP. While cranial CT is widely used for risk assessment, its predictive accuracy is debated. Although LP is relatively safe, herniation risk is highly context-dependent. Clinicians should integrate clinical, radiological, and pathophysiological factors in decision-making. Further research is needed to refine predictive models and establish evidence-based guidelines for high-risk patients.
- 14 August 2025
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 126 (1) , 23-34
Rethinking lumbar puncture safety: pathophysiology, diagnostic uncertainty, and research gaps in herniation risk
Lumbar puncture (LP) is a key diagnostic and therapeutic tool, yet concerns persist about its potential to induce brain herniation, especially in patients with elevated intracranial pressure (ICP). Despite ongoing debate, precise risk factors and pathophysiological mechanisms remain unclear. This systematic review aims to examine the risk of cerebellar and paradoxical brain herniation following LP, evaluate the current evidence regarding its incidence, and discuss the implications for clinical practice as well as show the gaps in research. Following PRISMA guidelines, a systematic literature review was conducted using the PubMed (MEDLINE) database. Studies from 1990 to 2024 focusing on bacterial meningitis, idiopathic intracranial hypertension, post-surgical states, and other conditions associated with elevated ICP were included. LP-related herniation was reported in diverse clinical settings, with cerebellar herniation primarily seen in bacterial meningitis and idiopathic intracranial hypertension. Herniation onset varied from minutes to days post-LP. While cranial CT is widely used for risk assessment, its predictive accuracy is debated. Although LP is relatively safe, herniation risk is highly context-dependent. Clinicians should integrate clinical, radiological, and pathophysiological factors in decision-making. Further research is needed to refine predictive models and establish evidence-based guidelines for high-risk patients.